Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. 

Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience.